How to buy a health care turnaround story at a discount using options
Dexcom (DXCM) excels in the medical device industry with innovative continuous glucose monitoring systems, attracting investor interest due to its growth potential despite competition. Recent breakout above $75 resistance level suggests a potential rally towards $110 target.